Table of Content
- introduction
- OBJECTIVES OF THE STUDY
- MARKET DEFINITION
- OVERVIEW of North America neonatal jaundice management market
- LIMITATIONs
- MARKETS COVERED
- MARKET SEGMENTATION
- MARKETS COVERED
- geographical scope
- years considered for the study
- currency and pricing
- DBMR TRIPOD DATA VALIDATION MODEL
- MULTIVARIATE MODELLING
- management LIFELINE CURVE
- primary interviews with key opinion leaders
- DBMR MARKET POSITION GRID
- vendor share analysis
- MARKET management COVERAGE GRID
- secondary sourcEs
- assumptions
- EXECUTIVE SUMMARY
- North America neonatal jaundice management market: Laws and regulations
- Market Overview
- Drivers
- Rising Patient Population Suffering from neonatal jaundice
- large number of risk factors
- rising number of NEW-BORN infants
- increase in preterm birth
- AWARENESS ABOUT NEONATAL JAUNDICE AMONG THE POPULATION
- restrainTs
- side-effects related to phototherapy
- product recalls
- limited adoption of neonatal jaundice management
- opportunities
- increasing healthcare expenditure
- technological advancement in diagnosis and treatment
- increasing disposable income
- increase in agreements and acquisitions
- challenges
- complications related to neonatal jaundice
- diagnosis of neonatal jaundice
- COVID-19 IMPACT ON North America neonatal jaundice management market
- IMPACT ON PRICE
- IMPACT ON DEMAND
- IMPACT ON SUPPLY CHAIN
- STRATEGIC DECISION FOR MANUFACTURERS / SERVICE PROVIDERS
- CONCLUSION
- North America neonatal jaundice management market, BY Management
- overview
- Diagnosis
- Transcutaneous Bilirubinometer (TCB)
- Total Serum Bilirubin (TSB)
- Visual Assessment
- Treatment
- Phototherapy
- LED PHOTOTHERAPY
- FIBER-OPTIC PHOTOTHERAPY
- CONVENTIONAL PHOTOTHERAPY
- CONVENTIONAL PHOTOTHERAPY WITH COMPACT FLUORESCENT LAMP
- CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP
- FULL-BODY PHOTOTHERAPY
- PARTIAL-BODY PHOTOTHERAPY
- Exchange Transfusion
- Intravenous Immunoglobulin
- Others
- North America neonatal jaundice management market, BY TYPE
- overview
- Primary CARE
- Secondary CARE
- North America neonatal jaundice management MARKET, BY TECHNOLOGY
- overview
- light-emitting diode light sources
- FIBER-OPTIC
- FLUORESCENT
- HALOGEN
- North America neonatal jaundice management market, BY end user
- overview
- hospitals
- clinics
- home users
- ambulatory surgical centers
- others
- North America neonatal jaundice management market, BY distribution channel
- overview
- direct tenders
- retail sales
- third party distribution
- North America neonatal jaundice management market: by country
- U.S.
- CANADA
- Mexico
- North America neonatal jaundice management market: COMPANY landscape
- company share analysis: north america
- SWOT
- company profiles
- signify holding
- COMPANY SNAPSHOT
- REVENUE FINANCIALS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- ge healthcare (A Subsidiary of general electric company)
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- atom medical corp.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- natus medical incorporated
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- dragerwerk AG & Co. KGaA
- COMPANY SNAPSHOT
- REVENUE ANALYSIS
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- herbert waldmann gmbh & co. Kg
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- aeroflow, inc.
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- ardo
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENT
- david
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- GINEVRI srl
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- neolight
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- neomedlight
- COMPANY SNAPSHOT
- PRODUCT PORTFOLIO
- RECENT DEVELOPMENTS
- questionnaire
- related reports
List of Table
TABLE 1 REGULATION imposed by several regulatory agencies
TABLE 2 RISK FACTORS FOR NEONATAL JAUNDICE
TABLE 3 CHARACTERISTICS OF TERM AND PRETERM INFANTS
TABLE 4 QUESTIONNAIRE FOR THE ONLINE FOLLOW-UP
TABLE 5 TIME SCHEDULE OF ONLINE FOLLOW-UP AFTER DISCHARGE
TABLE 6 North America neonatal jaundice management MARKET, By management, 2019-2028 (USD Million)
TABLE 7 NORTH AMERICA Diagnosis in Neonatal Jaundice Management Market, By Management, 2019-2028 (USD Million)
TABLE 8 NORTH AMERICA treatment in Neonatal Jaundice MANAGEMENT MARKET, By management, 2019-2028 (USD Million)
TABLE 9 NORTH AMERICA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD Million)
TABLE 11 North America Treatment By Conventional Phototherapy with Fluorescent Lamp in Neonatal Jaundice Management Market, By Management, 2019-2028 (USD Million)
TABLE 12 North America neonatal jaundice management MARKET, By TYPE, 2019-2028 (USD Million)
TABLE 13 North America neonatal jaundice management market, By Technology, 2019-2028 (USD Million)
TABLE 14 North America neonatal jaundice management market, By End User, 2019-2028 (USD Million)
TABLE 15 North America neonatal jaundice management market, By Distribution Channel, 2019-2028 (USD Million)
TABLE 16 North America neonatal jaundice management market, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 17 U.S. NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)
TABLE 18 U.S. diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)
TABLE 19 U.S. treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)
TABLE 20 U.S. TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 21 U.S. TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD Million)
TABLE 22 U.S. TREATMENT BY CONVENTIONAL PHOTOTHERAPY with Fluorescent Lamp IN NEONATAL JAUNDICE MANAGEMENT MARKET, By MANAGEMENT, 2019-2028 (USD Million)
TABLE 23 U.S. Neonatal jaundice management market, By Type, 2019-2028 (USD Million)
TABLE 24 U.S. Neonatal jaundice management market, By technology, 2019-2028 (USD Million)
TABLE 25 U.S. NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)
TABLE 26 U.S. NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)
TABLE 27 CANADA NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)
TABLE 28 CANADA diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)
TABLE 29 CANADA treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)
TABLE 30 CANADA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 31 CANADA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 32 CANADA TREATMENT BY CONVENTIONAL PHOTOTHERAPY with Fluorescent Lamp IN NEONATAL JAUNDICE MANAGEMENT MARKET, By MANAGEMENT, 2019-2028 (USD Million)
TABLE 33 CANADA Neonatal jaundice management market, By Type, 2019-2028 (USD Million)
TABLE 34 CANADA Neonatal jaundice management market, By technology, 2019-2028 (USD Million)
TABLE 35 CANADA NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)
TABLE 36 CANADA NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)
TABLE 37 Mexico NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)
TABLE 38 MEXICO diagnosis in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (Usd million)
TABLE 39 MEXICO treatment in NEONATAL JAUNDICE MANAGEMENT Market, By management, 2019-2028 (USD Million)
TABLE 40 MEXICO TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 41 MEXICO TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 42 MEXICO TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, By MANAGEMENT, 2019-2028 (USD Million)
TABLE 43 MEXICO Neonatal jaundice management market, By Type, 2019-2028 (USD Million)
TABLE 44 MEXICO Neonatal jaundice management market, By technology, 2019-2028 (USD Million)
TABLE 45 MEXICO NEONATAL JAUNDICE MANAGEMENT Market, By end user, 2019-2028 (USD Million)
TABLE 46 MEXICO NEONATAL JAUNDICE MANAGEMENT Market, By distribution channel, 2019-2028 (USD Million)
List of Figure
FIGURE 1 North America neonatal jaundice management market: SEGMENTATION
FIGURE 2 North America neonatal jaundice management market: DATA TRIANGULATION
FIGURE 3 North America neonatal jaundice management market: DROC ANALYSIS
FIGURE 4 North America neonatal jaundice management market: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 North America neonatal jaundice management market: COMPANY RESEARCH ANALYSIS
FIGURE 6 North America neonatal jaundice management market: MULTIVARIATE MODELLING
FIGURE 7 North America neonatal jaundice management market: INTERVIEW DEMOGRAPHICS
FIGURE 8 North America neonatal jaundice management market: DBMR MARKET POSITION GRID
FIGURE 9 North America neonatal jaundice management market: VENDOR SHARE ANALYSIS
FIGURE 10 North America neonatal jaundice management market: MARKET management COVERAGE GRID
FIGURE 11 NORTH AMERICA Bronchiectasis market: SEGMENTATION
FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM neonatal jaundice is DRIVing THE North America neonatal jaundice management market iN THE FORECAST PERIOD OF 2021 to 2028
FIGURE 13 Management SEGMENT is expected to account for the largest share of the North America neonatal jaundice management market in 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGEs OF North America neonatal jaundice management market
FIGURE 15 HEALTH SPENDING BY MAJOR NUMBER OF FUNDS
FIGURE 16 North America neonatal jaundice management MARKET: BY management, 2020
FIGURE 17 North America neonatal jaundice management market: BY management, 2019-2028 (USD MILLION)
FIGURE 18 North America neonatal jaundice management MARKET: BY management, CAGR (2021-2028)
FIGURE 19 North America neonatal jaundice management MARKET: BY management, LIFELINE CURVE
FIGURE 20 North America neonatal jaundice management market: BY Type, 2020
FIGURE 21 North America neonatal jaundice management market: BY type, 2019-2028 (USD MILLION)
FIGURE 22 North America neonatal jaundice management market: BY type, CAGR (2021-2028)
FIGURE 23 North America neonatal jaundice management MARKET: BY type, LIFELINE CURVE
FIGURE 24 North America neonatal jaundice management market: BY Technology, 2020
FIGURE 25 North America neonatal jaundice management market: BY Technology, 2019-2028 (USD MILLION)
FIGURE 26 North America neonatal jaundice management market: BY Technology, CAGR (2021-2028)
FIGURE 27 North America neonatal jaundice management market: BY Technology, LIFELINE CURVE
FIGURE 28 North America neonatal jaundice management MARKET: BY end user, 2020
FIGURE 29 North America neonatal jaundice management market: BY end user, 2019-2028 (USD MILLION)
FIGURE 30 North America neonatal jaundice management market: BY end user, CAGR (2021-2028)
FIGURE 31 North America neonatal jaundice management market: BY end user, LIFELINE CURVE
FIGURE 32 North America neonatal jaundice management market: BY distribution channel, 2020
FIGURE 33 North America neonatal jaundice management market: BY distribution channel, 2019-2028 (USD Million)
FIGURE 34 North America neonatal jaundice management market: BY distribution channel, CAGR (2021-2028)
FIGURE 35 North America neonatal jaundice management market: BY distribution channel, LIFELINE CURVE
FIGURE 36 North America neonatal jaundice management market: SNAPSHOT (2020)
FIGURE 37 North America neonatal jaundice management market: BY COUNTRY (2020)
FIGURE 38 North America neonatal jaundice management market: BY COUNTRY (2021 & 2028)
FIGURE 39 North America neonatal jaundice management MARKET: BY COUNTRY (2020 & 2028)
FIGURE 40 North America neonatal jaundice management market: BY management (2021-2028)
FIGURE 41 North America neonatal jaundice management market: company share 2020 (%)



